Skip to main content

Table 3 TGF-β-dependent stromal cell metabolic reprogramming in cancer

From: TGF-β signaling in the tumor metabolic microenvironment and targeted therapies

CAFs

NK cells (exhausted)

macrophages

Neutrophils/MDSCs

T cells (exhausted)

B cells

Stromal cell metabolic reprogramming

Glycolysis↑

Glycolysis↓

Glycolysis↑

Glycolysis↑

Glycolysis↓

Glycolysis↑

Fatty acid synthesis↑

Lipid accumulation ↑

Lipid accumulation ↑ FAO↑

FAO↑

Cholesterol↑ FAO↑

Further studies needed

Gln anabolism↑

Gln catabolism ↓

Gln and Arg catabolism↑

Gln catabolism↑

Arg and tryptophan metabolism↓

Gln catabolism↑

TGF-β-dependent stromal cell metabolic reprogramming

CAV-1↓ or ROS↑-Glycolysis↑

mTOR↓-Glycolysis↓

OXPHOS↑-M2 macrophages↑

Arginase↑-Pro-tumor features ↑

OXPHOS↑ and glycolysis↓, FAO ↑-Tregs↑

Further studies needed

a.IDH3α↓PDK1↑-TCA cycle↓ b. BCAT1 ↑-BCKAs↑

mTOR↓-OXPHOS↓

Arginase↑-Pro-tumor features ↑

CD39 and CD73↑-adenosine↑-Pro-tumor features ↓

ATP synthase↓-IFNγ↓-Effector function↓

Further studies needed

  1. MDSC myeloid-derived suppressor cells; Gln glutamine; FAO fatty acid oxidation; Arg arginine; CAV-1 caveolin-1; ROS reactive oxygen species; IDH3α isocitric dehydrogenase 3; BCAT1 branched chain amino acid transaminase 1; BCKAs branched-chain α-ketoacids; mTOR mammalian target of rapamycin; OXPHOS oxidative phosphorylation; Tregs regulatory T cells